Effect of dietary epigallocatechin-3-gallate on cytochrome P450 2E1-dependent alcoholic liver damage: Enhancement of fatty acid oxidation

Bioscience, Biotechnology and Biochemistry

Volumn 71, Issue 12, 2007, Pages 2999-3006

  Yun, Jun Won ^a   Kim, Young Kyung ^a   Lee, Byoung Seok ^a   Kim, Chae Wook ^a   Hyun, Jin Sook ^a   Baik, Joo Hyun ^a   Kim, Jung Ju ^a   Kim, Bae Hwan ^a  

^a AmorePacific Corporation   (South Korea)

Author keywords

Alcohol; Carnitine palmitoyl transferase 1 (CPT 1); Cytochrome P450 2E1 (CYP2E1); Epigallocatechin 3 gallate (EGCG); Phosphoacetyl CoA carboxylase (p ACC)

Indexed keywords

ENZYME ACTIVITY; ETHANOL; FATTY ACIDS; LIVING SYSTEMS STUDIES; OXIDATION;

ALCOHOLIC LIVER DAMAGE; ASPARTATE TRANSAMINASE (AST); CARNITINE PALMITOYL-TRANSFERASE;

PROTEINS;

ACETYL COENZYME A CARBOXYLASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE; CATECHIN; CYTOCHROME P450 2E1; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE;

ALCOHOLIC FATTY LIVER; ANIMAL; ARTICLE; DRUG EFFECT; ENZYME ACTIVATION; LIPID PEROXIDATION; MALE; METABOLISM; RAT; WISTAR RAT;

ACETYL-COA CARBOXYLASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CARNITINE O-PALMITOYLTRANSFERASE; CATECHIN; CYTOCHROME P-450 CYP2E1; ENZYME ACTIVATION; FATTY LIVER, ALCOHOLIC; LIPID PEROXIDATION; MALE; RATS; RATS, WISTAR;

EID: 37649021759     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70403     Document Type: Article

References (62)

1. Cahill, A., Cunningham, C. C., Adachi, M., Ishii, H., Bailey, S. M., Fromenty, B., and Davies, A., Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion. Alcohol Clin. Exp. Res., 26, 907-915 (2002).
2. Castilla, R., Gonzalez, R., Fouad, D., Fraga, E., and Muntane, J., Dual effect of ethanol on cell death in primary culture of human and rat hepatocytes. Alcohol Alcohol., 39, 290-296 (2004).
3. Clot, P., Tabone, M., Arico, S., and Albano, E., Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut, 35, 1637-1643 (1994).
4. Navasumrit, P., Ward, T. H., Dodd, N. J., and O'Connor, P. J., Ethanol-induced free radicals and hepatic DNA strand breaks are prevented in vivo by antioxidants: effects of acute and chronic ethanol exposure. Carcinogenesis, 21, 93-99 (2000).
5. Ozaras, R., Tahan, V., Aydin, S., Uzun, H., Kaya, S., and Senturk, H., N-acetylcysteine attenuates alcohol-induced oxidative stress in the rat. World J. Gastroenterol., 9, 125-128 (2003).
6. Poli, G., and Parola, M., Oxidative damage and fibrogenesis. Free Radic. Biol. Med., 22, 287-305 (1997).
7. Song, B. J., Ethanol-inducible cytochrome P450 (CYP2E1): biochemistry, molecular biology and clinical relevance: 1996 update. Alcohol Clin. Exp. Res., 20 (8 Suppl), 138A-146A (1996).
8. Moncion, A., Truong, N. T., Garrone, A., Beaune, P., Barouki, R., and De Waziers, I., Identification of a 16-nucleotide sequence that mediates post-transcriptional regulation of rat CYP2E1 by insulin. J. Biol. Chem., 277, 45904-45910 (2002).
9. Gonzalez, F. J., Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat. Res., 569, 101-110 (2005).
10. Dai, Y., Rashba-Step, J., and Cederbaum, A. I., Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry, 32, 6928-6937 (1993).
11. Castillo, T., Koop, D. R., Kamimura, S., Triadafilopoulos, G., and Tsukamoto, H., Role of cytochrome P-450 2E1 in ethanol, carbon tetrachloride-, and iron-dependent microsomal lipid peroxidation. Hepatology, 16, 992-996 (1992).
12. Woodcroft, K. J., and Novak, R. F., The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expression. Biochem. Biophys. Res. Commun., 266, 304-307 (1999).
13. Robertson, G., Leclercq, I., and Farrell, G. C., Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am. J. Physiol. Gastrointest. Liver Physiol., 281, G1135-G1139 (2001).
14. Lieber, C. S., The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab. Rev., 36, 511-529 (2004).
15. Lieber, C. S., Role of oxidative stress and antioxidant therapy in alcoholic and non alcoholic liver diseases. Adv. Pharmacol., 38, 601-628 (1997).
16. Cervinkova, Z., and Drahota, Z., Internal administration of lipid emulsion protects liver cytochrome C oxidase from hepatotoxic action of thioacetamide. Physiol. Res., 47, 151-154 (1998).
17. Balentine, D. A., Wiseman, S. A., and Bouwens, L. C., The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr., 37, 693-704 (1997).
18. Sano, M., Tabata, M., Suzuki, M., Degawa, M., Miyase, T., and Maeda-Yamamoto, M., Simultaneous determination of twelve tea catechins by high-performance liquid chromatography with electrochemical detection. Analyst, 126, 816-820 (2001).
19. Moyers, S. B., and Kumar, N. B., Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr. Rev., 62, 204-211 (2004).
20. Park, O. J., and Surh, Y. J., Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol. Lett., 150, 43-56 (2004).
21. Mandel, S., Weinreb, O., Amit, T., and Youdim, M. B., Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J. Neurochem., 88, 1555-1569 (2004).
22. Lambert, J. D., and Yang, C. S., Mechanisms of cancer prevention by tea constituents. J. Nutr., 133, 3262S-3267S (2003).
23. Higdon, J. V., and Frei, B., Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr., 43, 89-143 (2003).
24. Benelli, R., Vene, R., Bisacchi, D., Garbisa, S., and Albini, A., Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol. Chem., 383, 101-105 (2002).
25. Jung, Y. D., and Ellis, L. M., Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int. J. Exp. Pathol., 82, 309-316 (2001).
26. You, M., and Crabb, D. W., Recent advances in alcoholic liver disease. II. Minireview: molecular mechanisms of alcoholic fatty liver. Am. J. Physiol. Gastrointest. Liver Physiol., 287, G1-G6 (2004).
27. Lieber, C. S., and DeCarli, L. M., Liquid diet technique of ethanol administration: 1989 update. Alcohol Alcohol., 24, 197-211 (1989).
28. Bissell, D. M., Gores, G. J., Laskin, D. L., and Hoofnagle, J. H., Drug-induced liver injury: mechanisms and test systems. Hepatology, 33, 1009-1013 (2001).
29. Larrey, D., Drug-induced liver diseases. J. Hepatol., 32(1 Suppl), 77-88 (2000).
30. Lee, W. M., Drug-induced hepatotoxicity. N. Engl. J. Med., 349, 474-481 (2003).
31. Kasdallah-Grissa, A., Mornagui, B., Aouani, E., Hammami, M., El May, M., Gharbi, N., Kamoun, A., and El-Fazaa, S., Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci., 80, 1033-1039 (2007).
32. Arteel, G. E., Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology, 124, 778-790 (2003).
33. Morimoto, M., Hagbjork, A. L., Nanji, A. A., Ingelman-Sundberg, M., Lindros, K. O., Fu, P. C., Albano, E., and French, S. W., Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol, 10, 459-464 (1993).
34. Tsukamoto, H., Cyp2e1 and ALD. Hepatology, 32, 154-156 (2000).
35. Senthilkumar, R., and Nalini, N., Effect of glycine on tissue fatty acid composition in an experimental model of alcohol-induced hepatotoxicity. Clin. Exp. Pharmacol. Physiol., 31, 456-461 (2004).
36. Park, H., Kaushik, V. K., Constant, S., Prentki, M., Przybytkowski, E., Ruderman, N. B., and Saha, A. K., Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J. Biol. Chem., 277, 32571-32577 (2002).
37. Nieto, N., Friedman, S. L., and Cederbaum, A. I., Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology, 35, 62-73 (2002).
38. Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S., and Cooper, G. J., The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest., 112, 91-100 (2003).
39. Ramsay, R. R., Gandour, R. D., and van der Leij, F. R., Molecular enzymology of carnitine transfer and transport. Biochim. Biophys. Acta, 1546, 21-43 (2001).
40. Vaz, F. M., and Wanders, R. J. A., Carnitine biosynthesis in mammals. Biochem. J., 361, 417-429 (2002).
41. Chien, D., Dean, D., Saha, A. K., Flatt, J. P., and Ruderman, N. B., Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo. Am. J. Physiol. Endocrinol. Metab., 279, E259-E265 (2000).
42. Hardie, D. G., and Carling, D., The AMP:activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem., 246, 259-273 (1997).
43. Park, K. J., Lee, M. J., Kang, H., Kim, K. S., Lee, S. H., Cho, I., and Lee, H. H., Saeng-Maek-San, a medicinal herb complex, protects liver cell damage induced by alcohol. Biol. Pharm. Bull., 25, 1451-1455 (2002).
44. Winder, W. W., and Hardie, D. G., AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol., 277(1 Pt 1), E1-E10 (1999).
45. Ruderman, N. B., Saha, A. K., Vavvas, D., and Witters, L. A., Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol., 276(1 Pt 1), E1-E18 (1999).
46. Tomas, E., Tsao, T. S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., Lodish, H. F., and Ruderman, N. B., Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. USA, 99, 16309-16313 (2002).
47. Graham, H. N., Green tea composition, consumption and polyphenol chemistry. Prev. Med., 21, 334-350 (1992).
48. Rice-Evans, C. A., Miller, N. J., and Paganga, G., Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med., 20, 933-956 (1996).
49. Stoner, G. D., and Mukhtar, H., Polyphenols as cancer chemopreventive agents. J. Cell Biochem. Suppl., 22, 169A-180A (1995).
50. Arteel, G. E., Uesugi, T., Bevan, L. N., Gabele, E., Wheeler, M. D., McKim, S. E., and Thurman, R. G., Green tea extract protects against early alcohol-induced liver injury in rats. Biol. Chem., 383, 663-670 (2002).
51. Giakoustidis, A. E., Giakoustidis, D. E., Iliadis, S., Papageorgiou, G., Koliakou, K., Kontos, N., Taitzoglou, I., Botsoglou, E., Papanikolaou, V., Atmatzidis, K., Takoudas, D., and Antoniadis, A., Attenuation of intestinal ischemia/reperfusion induced liver and lung injury by intraperitoneal administration of (-)-epigallocatechin-3-gallate. Free Radic. Res., 40, 103-110 (2006).
52. Sadzuka, Y., Inoue, C., Hirooka, S., Sugiyama, T., Umegaki, K., and Sonobe, T., Effects of theanine on alcohol metabolism and hepatic toxicity. Biol. Pharm. Bull., 28, 1702-1706 (2005).
53. Jimenez-Lopez, J. M., and Cederbaum, A. I., Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1-dependent toxicity. Free Radic. Biol. Med., 36, 359-370 (2004).
54. Van Acker, S. A., van den Berg, D. J., Tromp, M. N., Griffioen, D. H., van Bennekom, W. P., van der Vijgh, W. J., and Bast, A., Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med., 20, 331-342 (1996).
55. Guo, Q., Zhao, B., Shen, S., Hou, J., Hu, J., and Xin, W., ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim. Biophys. Acta, 1427, 13-23 (1999).
56. McDonough, K. H., Antioxidant nutrients and alcohol. Toxicology, 189, 89-97 (2003).
57. Skrzydlewska, E., Ostrowska, J., Stankiewicz, A., and Farbiszewski, R., Green tea as a potent antioxidant in alcohol intoxication. Addict. Biol., 7, 307-314 (2002).
58. Arakawa, H., Maeda, M., Okubo, S., and Shimamura, T., Role of hydrogen peroxide in bactericidal action of catechin. Biol. Pharm. Bull., 27, 277-281 (2004).
59. Nakagawa, H., Hasumi, K., Woo, J. T., Nagai, K., and Wachi, M., Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis, 25, 1567-1574 (2004).
60. Maeta, K., Nomura, W., Takatsume, Y., Izawa, S., and Inoue, Y., Green tea polyphenols function as prooxidants to activate oxidative-stress-responsive transcription factors in yeasts. Appl. Environ. Microbiol., 73, 572-580 (2007).
61. Hardie, D. G., Carling, D., and Carlson, M., The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell. Annu. Rev. Biochem., 67, 821-855 (1998).
62. Hwang, J. T., Park, I. J., Shin, J. I., Lee, Y. K., Lee, S. K., Baik, H. W., Ha, J., and Park, O. J., Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem. Biophys. Res. Commun., 338, 694-699 (2005).